BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand

llumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of So...

June 01, 2021 | News

Nexturn Bio Inc. acquired a 50% stake in RosVivo Therapeutics, Inc.

Nexturn Bio Inc., a subsidiary of Nexturn Bioscience Co., Ltd., announced on May 26th that it had acquired a 50% stake in RosVivo Therapeutics In...

May 31, 2021 | News

Avance Clinical Releases Industry Survey Results at BIO Korea 2021

The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a rec...

May 27, 2021 | News

Multiply Labs Joins forces with Cytiva to automate cell therapy manufacturing.

Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibi...

May 26, 2021 | News

Cytiva and Prestige Biopharma to accelerate manufacturing COVID-19 vaccines and antibody therapies.

Cytiva and Prestige Biopharma have formed a collaboration to accelerate manufacturing COVID-19 vaccines and antibody therapies. With Cytiva’s cell cu...

May 26, 2021 | News

Most COVID-19 Patients Have Long-term Neurological Problems

In a surprise, however, a research team at NYU Grossman School of Medicine also found that 91 percent of patients, whether or not they had a neurological d...

May 25, 2021 | Analysis

Hyundai Bioscience to proceed to clinical trial with CP-COV03

A study on CNPharm's antiviral oral formulation published in a special edition of Pharmaceuticals Hyundai Bioscience (KOSDAQ 048410) announced on ...

May 24, 2021 | News

Moderna and South Korea Explore Collaboration on mRNA Vaccines

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced two Memoranda of Unde...

May 24, 2021 | News

Moderna and Samsung Biologics Announce Agreement for Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine

Moderna (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Samsung Biologics (KRX: 207940.KS), a leadin...

May 24, 2021 | News

'CUVIS-spine' acquired FDA (US) licensing.

'CUVIS-spine' is available in all countries by acquiring the license from the FDA (US), Korea and Europe. 'CUVIS-spine' reduces surgery duration wi...

May 22, 2021 | News

Cytiva launches sustainability plan - ‘Designing in sustainability’

Cytiva sets out a sustainability plan to positively affect people and the planet, which underpins business resilience in a fast-changing world Performan...

May 13, 2021 | News

Navigo Proteins and MDimune Enter into a Research Collaboration

Navigo Proteins, a protein engineering biotech company generating scaffold protein-based affinity ligands, and MDimune, a biotech company developing an inn...

May 11, 2021 | News

Cytiva strengthens commitment to foster talent pool in Korea

Cytiva is building its presence in the Korean market by expanding collaborations with top academic institutions. On April 27, we signed a memorandum of un...

May 08, 2021 | News

Samsung Biologics and TG Therapeutics to enable global manufacturing of ublituximab

Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization and TG Therapeutics (NASDAQ: TGTX), today...

April 26, 2021 | News

Stay Connected